×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Dr Gwenaël Ferron et Pr Jean-Emmanuel Kurtz
Intervenants : Dr Anne Ducassou,  Pr Jérôme Alexandre, Pr Florence Joly, Dr Alexandra Leary, Dr Gwenaël Ferron & Pr Jean-Emmanuel Kurtz
 

Rechute du cancer de l’endomètre : choix thérapeutique - webinar 4
 

18:00
Rechute localisée : place de la chirurgie de rattrapage pelvien et de la radiothérapie
Dr Anne Ducassou et Dr Gwenaël Ferron - IUCT Oncopole Toulouse
 
18:15
Place de l’hormonothérapie en première ligne métastatique
Pr Jerôme Alexandre - APHP Hôpital Cochin, Paris
 
18:30 Quel traitement de première et deuxième ligne ?
Pr Jean-Emmanuel Kurtz - ICANS Strasbourg
 
18:45
Place future de l’immunothérapie en première ligne métastatique ?
Pr Florence Joly - Centre François Baclesse, Caen
 
19:00
Nouvelles cibles thérapeutiques (HER2, FGFR…)
Dr Alexandra Leary - Institut Gustave Roussy, Villejuif
 
19:15
Débat/Discussion - Réponses aux questions

 

Cycle de formation en 4 webinars :

Découvrez les autres webinars :

Shooting date : 2021-09-27
Last update : 2021-09-28

Suggestions

Monday, October 7th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, October 7th 2024 from 06am to 07:30am (GMT+2)
San Francisco : Monday, October 7th 2024 from 09am to 10:30am (GMT+2)
New York : Monday, October 7th 2024 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Monday, October 7th 2024 from 01pm to 02:30pm (GMT+2)
Reykjavik : Monday, October 7th 2024 from 04pm to 05:30pm (GMT+2)
London / Dublin : Monday, October 7th 2024 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, October 7th 2024 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, October 7th 2024 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, October 7th 2024 from 08pm to 09:30pm (GMT+2)
Bangkok : Monday, October 7th 2024 from 11pm to 12:30am (GMT+2)
Shanghai : Tuesday, October 8th 2024 from 12am to 01:30am (GMT+2)
Tokyo : Tuesday, October 8th 2024 from 01am to 02:30am (GMT+2)
Sydney : Tuesday, October 8th 2024 from 03am to 04:30am (GMT+2)
Wellington : Tuesday, October 8th 2024 from 05am to 06:30am (GMT+2)

HPV : Tous protégés !

Share
Monday, November 27th 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, November 27th 2023 from 06am to 07:30am (GMT+1)
San Francisco : Monday, November 27th 2023 from 08am to 09:30am (GMT+1)
New York : Monday, November 27th 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 27th 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 27th 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 27th 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 27th 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 27th 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 27th 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 28th 2023 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 28th 2023 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 28th 2023 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 28th 2023 from 04am to 05:30am (GMT+1)

Point sur la place de l’immunothérapie dans les cancers gynécologiques

Cycle d'enseignement - Les cancers gynécologiques

Share
Thursday, September 7th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Thursday, September 7th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Thursday, September 7th 2023 from 09am to 10:30am (GMT+2)
New York : Thursday, September 7th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Thursday, September 7th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Thursday, September 7th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Thursday, September 7th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Thursday, September 7th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Thursday, September 7th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Thursday, September 7th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Thursday, September 7th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Friday, September 8th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Friday, September 8th 2023 from 01am to 02:30am (GMT+2)
Sydney : Friday, September 8th 2023 from 03am to 04:30am (GMT+2)
Wellington : Friday, September 8th 2023 from 05am to 06:30am (GMT+2)

Septembre Turquoise

L'activité physique pendant les traitements et après la maladie

Share
Wednesday, October 18th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, October 18th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Wednesday, October 18th 2023 from 09am to 10:30am (GMT+2)
New York : Wednesday, October 18th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Wednesday, October 18th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Wednesday, October 18th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Wednesday, October 18th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Wednesday, October 18th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, October 18th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Wednesday, October 18th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Wednesday, October 18th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Thursday, October 19th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Thursday, October 19th 2023 from 01am to 02:30am (GMT+2)
Sydney : Thursday, October 19th 2023 from 03am to 04:30am (GMT+2)
Wellington : Thursday, October 19th 2023 from 05am to 06:30am (GMT+2)

Cancer du col épisode 1 : Prise en charge du cancer du col débutant

HPV : dépistage, prévention et traitement des cancers HPV induits

Share
Scroll Up